The purpose of this study was to determine the influence of 14 days of normobaric hypoxic simulated altitude exposure at 3000 m on the human plasma metabolomic profile. For 14 days, 10 well-trained endurance runners (six men and four women; 29 ± 7 years of age) lived at 3000 m simulated altitude, accumulating 196.4 ± 25.6 h of hypoxic exposure, and trained at ∼600 m.
INTRODUCTION
Endurance athletes commonly use several weeks of exposure to moderate altitude (2000-3000 m; Bartsch & Saltin, 2008) to increase their oxygen-carrying capacity and subsequent athletic performance (Gore et al., 2013) . During such exposure, every 100 h of hypoxic exposure at ∼2200 m can increase haemoglobin mass by ∼1% (Gore et al., 2013) through the upregulation of erythropoietin (Rusko, Tikkanen, & Peltonen, 2004) . In these conditions, an increase of ≤4% in power output, maximal oxygen consumption and red cell mass at sea level have been observed (Bonetti & Hopkins, 2009 ). In addition to the expansion of red blood cell mass, non-haematological changes, including improvements in exercise economy, skeletal muscle buffering and increases in oxidative and glycolytic enzymes, have all been observed after moderate altitude exposure and are associated with a postexposure increase in performance (Gore, Clark, & Saunders, 2007) .
However, improvements in performance after prolonged altitude exposure have also been observed in the absence of changes to haematological and/or non-haematological variables (Bartsch & Saltin, 2008; Gore et al., 1998 Gore et al., , 2001 . It is possible that unknown physiological adaptations after altitude exposure are responsible for the observed increase in performance or that it is not possible to quantify the magnitude of change in the identified haematological and nonhaematological variables accurately (Gore et al., 1998) .
Metabolomics is the comprehensive analysis of metabolites, which are the end-product of gene expression in a biological system (Dunn, Broadhurst, Atherton, Goodacre, & Griffin, 2011) , and might provide a viable technique to expand current understanding of the physiological adaptations associated with altitude exposure.
Indeed, given that oxygen is the terminal electron acceptor in the mitochondrial respiratory chain and that central energy metabolism is intricately linked to global metabolism, characterizing the metabolic changes that occur during prolonged altitude exposure might identify previously unknown pathways of change that could influence exercise performance. Liquid chromatography-high-resolution mass spectrometry is a commonly used method for the untargeted detection of metabolites, owing to its ability to resolve thousands of metabolite features with a single sample. This technique enables accurate mass determination (p.p.m. error) without compromising sensitivity, ensuring maximal detection of metabolites in complex matrices. In addition, metabolomics requires only small sample volumes (∼50 l), thus enabling the collection of biological fluids more frequently from human subjects in a variety of contexts. Recently, metabolomic studies using nuclear magnetic resonance and mass spectrometry have enabled investigation of the effects of hypoxia in human, animal and cell models (Armitage et al., 2015; D'Alessandro et al., 2016; Liao et al., 2016; Lou, Wu, Liu, & Wang, 2014) , revealing changes in pathways such as central carbon, purine and lipid metabolism.
Although a large volume of research has been conducted in an attempt to understand the haematological and non-haematological changes associated with altitude exposure, there are large inter-and intra-individual differences (McLean, Gore, & Kemp, 2014) in the physiological response to moderate exposure, indicating that further research is necessary. The primary aim of the present study was
New Findings
• What is the central question of this study? Does 14 days of live-high, train-low simulated altitude alter an individual's metabolomic/metabolic profile?
• What is the main finding and its importance?
This study demonstrated that ∼200 h of moderate simulated altitude exposure resulted in greater variance in measured metabolites between subject than within subject, which indicates individual variability during the adaptive phase to altitude exposure. In addition, metabolomics results indicate that altitude alters multiple metabolic pathways, and the time course of these pathways is different over 14 days of altitude exposure.
These findings support previous literature and provide new information on the acute adaptation response to altitude.
to use liquid chromatography-high-resolution mass spectrometry of plasma samples to examine the following: (i) the influence of 14 days of normobaric, simulated altitude (3000 m) on the metabolic profile of 10 highly trained middle-distance runners; and (ii) the utility of metabolomics methods to yield insights into physiological adaptations to altitude exposure.
METHODS

Ethical approval
This study was approved by the Human Research Ethics Committee at Edith Cowan University (reference no. 8064) and complied with the guidelines set out in the Declaration of Helsinki, except for registration in a database. Written informed consent was obtained from all participants before participation in the study.
Participants
Ten well-trained, healthy middle-distance runners (six men and four women) were recruited from the local running community (mean ± SD age 28.6 ± 6.7 years; body mass 62.6 ± 7.6 kg; maximal oxygen consumption 65.6 ± 8.1 ml kg −1 min −1 ) to participate in this study.
Participants were included if they had ≥2 years of competitive running experience and trained at least three times per week. Participants were screened before the study for iron deficiency and were excluded if deemed to be stage 2 iron deficient (serum ferritin <20 g l −1 ; Peeling et al., 2007) . Participants were instructed to maintain their normal training schedule during the study, but to refrain from caffeine, alcohol and strenuous physical activity on the day of blood sampling.
All participants self-reported compliance with these requirements.
Data for this study were collected as part of a larger observational study examining the influence of 14 days of altitude exposure (∼3000 m), from which changes in haemoglobin mass, haematocrit (as a percentage), haemoglobin concentration and erythropoietin have been reported elsewhere (Govus et al., 2017) .
Altitude exposure
Participants were exposed to 14 consecutive days of normobaric hypoxia (3000 m) as part of an 'altitude training camp' . The hypoxic environment was maintained within a purpose-built altitude house facility using oxygen filtration (Kinetic Performance Technology, Canberra, ACT, Australia). The goal of the training camp was to expose participants to ≥200 h (Gore et al., 2013) of hypoxic exposure (with a minimum of 14 h day −1 ). Participants maintained their normal training schedules during the 14 day experiment, with all training conducted near sea level (600 m terrestrial altitude). In addition to normal training, participants completed four running interval-based training sessions (6 × 1000 m at 90% of maximal aerobic running velocity) on separate days (two in normoxic conditions and two in hypoxic conditions) during the week preceding the 14 days of altitude exposure, and during days 11 and 14 of hypoxic exposure, which were used to monitor iron levels after exercise in response to chronic altitude exposure (Govus et al., 2017) . The normoxic sessions were conducted on a 400 m synthetic running track (600 m terrestrial altitude), whereas hypoxic sessions were conducted at 3000 m simulated altitude on a motorized treadmill. Each interval session commenced with a 15 min warm-up, composed of self-paced, continuous low-intensity running, followed by 10 min of dynamic stretching. The details of exercise measurements for this group are described elsewhere (Govus et al., 2017) .
Sample collection
Blood sampling was performed at three time points (baseline and days 3 and 14) during the 14 days of altitude exposure. Participants provided 2 ml of blood from the antecubital vein after 10 min of supine rest to normalize plasma volume shifts (Ahlgrim et al., 2010 ) into a 1 × 2 ml lithium heparin vacutainer tube. The tube was immediately centrifuged 2200g for 10 min, and plasma was collected into 500 l aliquots and stored −80 • C until metabolomic analysis.
Sample preparation for metabolomics analyses
Plasma samples were prepared using the Bligh and Dyer method (Bligh & Dyer, 1959) in randomized batches of 24. In brief, samples were thawed on ice and a 200 l aliquot was mixed 3:1:1 (v/v/v) analytical grade methanol (MeOH)/chloroform (CHCl 3 )/plasma, followed by two volumes of analytical grade water. To measure extraction efficiency and monitor mass spectrometry performance, the internal standard trans-cinnamic acid-,2,3,4,5,6-d6 (Sigma Aldrich, St Louis, MO, USA) was added to the MeOH phase. Samples were vortexed during each phase for ∼15 s and thermomixed for 10 min at 4 • C and 1400 r.p.m.
Samples were then centrifuged for 10 min at 4 • C at 16,100g. Polar extracts were transferred to microcentrifuge tubes and MeOH was removed using a rotary vacuum concentrator. Samples were snap frozen using liquid N 2 , lyophilized and stored at −80 • C until analysis.
Dried extracts were reconstituted in 50 l of 0.1% formic acid in water and maintained at 10 • C in the autosampler. Before data acquisition, the analytical sequence was randomized by participant and then time point. To monitor analytical drift and assess precision, quality control (QC) samples were injected after every fifth sample (Dunn, Wilson, Nicholls, & Broadhurst, 2012) . The QC samples were prepared by pooling 20 l of each plasma sample; 50 l aliquots were then prepared as for study samples.
Liquid chromatography-mass spectrometry
Samples were analysed using a Waters ACQUITY ultra performance liquid chromatograph (UPLC; Waters Corp., Milford, MA, USA) system coupled to a SCIEX TripleTOF 5600 mass spectrometer (SCIEX, Concord, ON, Canada). Metabolite separation was performed using the Waters Acquity BEH C18 column (2.1 mm × 100 mm, 1.7 m particle size; Waters Corp.). The elution gradient using 0.1% formic acid in water (solvent A) and 0.1% formic acid in acetonitrile (solvent B) was as follows: isocratic step at 1% B for 1 min, 1 to 99.5% B in 36 min, maintained at 99.5% B for 2 min, returned to initial conditions for 1 min, and then equilibration at initial conditions for 5 min. The flow rate was 0.3 mL min −1 , injection volume was 10 l, and the column oven was maintained at 35 • C.
Full scan mass spectrometry data in high resolution were acquired in both electrospray ionization positive and negative (ESI+/−) in a mass range of m/z 50-1000 according to the following parameters: nebulizer gas (N 2 ) 45 p.s.i., heater gas (N 2 ) 50 p.s.i., curtain gas 30 p.s.i., and ion source temperature of 550 • C. An IonSpray voltage of 5500 V was used for positive-ion acquisition and -4500 V for negative-ion acquisition. Tandem mass spectrometry (MS/MS) were collected on all acquired samples to aid in metabolite identification. Independent data acquisition was used on the TripleTOF 5600 to obtain MS/MS spectra for the five most abundant precursor ions after each survey scan. A sweeping collision energy setting of 35 ± 15 eV was applied in the collision cell using N 2 as the collision gas. An exact mass calibration was conducted automatically before each batch analysis and at every sixth sample thereafter. The instrument was calibrated before the analysis (calibration error <3 p.p.m.) using 0.5 mM sodium formate for both positive and negative ionization. The TripleTOF 5600 mass spectrometer used Analyst control software v1.6 for data acquisition.
Data preprocessing
Data from each MS ionization mode were grouped and pre-processed separately. Raw MS files were converted to universal mzXML format using MSconvert (Chambers et al., 2012) , then processed using XCMS (Smith, Want, O'Maille, Abagyan, & Siuzdak, 2006) in R (R v.3.1.1; https://cran.r-project.org/). Peak detection and alignment were completed using the following parameters: method = 'centWave' , ppm = 10, peak width = 5-20, snthresh = 6, mzdiff = 0.01, retention time correction method = 'obiwarp' and mzdiff = 0.01.
Experimental drift was corrected using the Quality Control-Robust Spline Correction (QC-RSC) algorithm (Kirwan, Broadhurst, Davidson, & Viant, 2013) . Relative standard deviations were calculated for the pooled QC injections (RSDQC) and the sample injections (RSDSample), and the ratio of RSDsample to RSDQC was also calculated. Features with >25% RSDQC or RSD ratio <2 were considered not sufficiently reproducible and removed before statistical analysis.
To suppress the mathematical confounding effect of highly collinear data (and roughly to group chemically similar features, such as adducts and isotopes), metabolite features were combined into a single peak using a simple clustering algorithm. First, a Pearson's correlation matrix was calculated, mapping the pairwise correlation between each metabolite feature. Second, a retention time difference matrix was calculated, mapping the pairwise difference in retention time between each metabolite feature. Features that had a pairwise correlation >0.8 and pairwise retention time difference < ±1 s were grouped into a single metabolite 'cluster' . For each cluster, the feature with the largest peak area was then used for quantification. Orphan features were considered as clusters with n = 1. 
Metabolite identification
Statistical analysis
The metabolite cluster data from both the positive and negative ionization modes were combined into a single data matrix. Missing values were imputed using the k-nearest-neighbour methodology (k = 3; Speed, 2003) . Data were logarithmically transformed, both to stabilize variance and to approximate the multivariate normal distribution needed for parametric univariate and multivariate statistical modelling.
Before any formal models were tested, principal components analysis (PCA) was performed on the complete data set, with scores plot labelled by QC and subject. Here, the aim is to assess the natural multivariate variance of the data. If the experiment has been performed well, it is expected that the QC samples will cluster tightly, such that the QC variance is less than the total sample variance. Also, this is an opportunity to identify and remove sample outliers resulting from either poor sample collection or instrument error.
Metabolites were separated into identified and unidentified data sets. For each metabolite in turn, the null hypothesis that there were no differences in population means across the three consecutive time points was tested using repeated-measures analysis of variance (RM-ANOVA). The method described by Storey & Tibshirani (2003) was used to control for the probability of false discovery, which is unavoidably inflated through multiple parallel statistical comparisons.
A false discovery rate (FDR) of 0.1 was considered appropriate as a first-pass screen to avoid false-positive biomarkers, whilst at the same time avoiding false-negative results. For the identified metabolites, results were presented in a table of F-scores, P values, FDR probabilities (pFDR), and additionally, mean fold differences (±95% confidence interval) for day 3/baseline and day 14/baseline.
Where appropriate, univariate data were also presented as plots of estimated marginal means relative to the factor 'time' .
The identified peaks were then combined into a single multivariate discriminant model using principal component projection followed by canonical variate analysis (PC-CVA; Krzanowski, 1988) . The PC-CVA is performed to visualize the multivariate covariance in the data and uncover multivariate latent structure therein. Often univariately weak, but correlated, variables can become significant when combined into a multifactorial biomarker signature. The number of PCs to be projected into CVA space was determined by identifying the inflection point in the PCA scree plot. Bootstrap resampling/remodelling was used (n = 500) to determine which metabolites contributed significantly to the optimal model (P < 0.05).
Data mining of unidentified metabolite features
To determine the strength and the direction of the linear relationship between all identified and unidentified significant metabolite features (pFDR < 0.1), undirected network analysis was performed in the form of a spring-embedded correlation plot (Broadhurst & Kell, 2006) . First, a Pearson's correlation matrix was calculated, mapping the pairwise correlation between each significant metabolite feature. The results of the correlation matrix were presented graphically as a network of 'nodes' linked by 'edges' . Each node represents a metabolite, such that the size of the node is proportional to the significance of the metabolite (the larger the node, the lower the P value). Edges represent a spring constant that is proportional to the correlation coefficient between two metabolites. Edges were included only if the correlation coefficient was positive and significant at a critical P value of 0.001. Once the network was constructed, it was allowed to 'relax'; the connected spring edges compete against each other to pull nodes in a given direction based on the spring constant (i.e. the higher the correlation, the stiffer the spring and the higher the clustering power). The resulting spring-embedded plot can be viewed as a multivariate cluster analysis, with highly correlated metabolites clustering closer together. Node colour directly maps to the linear correlation coefficient between metabolite concentration and time (red = positive correlation; blue = negative correlation). To aid interpretation of the network, non-significant but identified metabolites were included in the spring plot (labelled in grey), based on the premise that metabolites performing a similar function, or belonging to a similar class, will cluster. Networks were coded using the graph visualization software Graphviz (www.graphviz.org), using the 'neato' virtual physics model. All statistical analysis was performed using Matlab scripting language, vR2017a (Mathworks, Natick, MA, USA).
TA B L E 1
Putatively annotated metabolic features were estimated using 500 iterations of bootstrap resampling.
F I G U R E 1
Principal components (PC) analysis scores plot showing all experimental samples of the 3001 reproducible peaks. The quality control (QC) samples (red) were formed from pooling small quantities from each sample, and they cluster tightly in the plot
RESULTS
Altitude exposure
Over 14 days, participants accumulated 196.2 ± 25.6 h of normobaric hypoxic exposure, resulting in a significant increase (2.2%) in haemoglobin mass from baseline values (783.7 versus 801.5 g).
The details of these measurements have been reported elsewhere (Govus et al., 2017) .
Metabolomics data
After data cleaning and similarity clustering, liquid chromatography- (Table 1) .
Principal components analysis showed (Figure 1 ) that the QC samples clustered tightly and that the QC variance was much smaller than the sample variance. Additionally, it can be observed that across the total measured metabolome, between-subject variance was much greater than within-subject variance. There were no outliers detected.
After RM-ANOVA using a critical P value of 0.03 (pFDR = 0.1), 173 metabolites were found to be statistically significant when compared with baseline [70 in ESI (+) mode and 103 in ESI (−) mode]. Of the 36 identified metabolites, eight were statistically significant compared with baseline. Five metabolites showed a significant disruption followed by recovery trajectory (bilirubin increased in the first 3 days and then returned to normal at day 14; glycocholic acid, proline, tyrosine and lactic acid decreased in the first 3 days and then returned to baseline at day 14). Three metabolites displayed a significant non-recovery trajectory (adenosine and glycoursodeoxycholic acid decreased in the first 3 days, but then showed only a slight return to baseline at day 14; tiglylcarnitine increased in the first 3 days and then continued to increase to day 14).
Using a four principal components projection, the results of PC-CVA 
DISCUSSION
In the present study, we examined the metabolic changes during 14 days of normobaric hypoxia (∼3000 m) in well-trained endurance runners. Using metabolomics, we demonstrated that ∼200 h of moderate simulated altitude exposure resulted in greater variance in measured metabolites between person rather than within person, which indicates individual variability during the adaptive phase to altitude exposure. Additionally, we were able to visualize a metabolic profile associated with altitude exposure. From these data, we observed a significant shift in the plasma metabolite profile after 3 days of altitude exposure, with a return towards baseline by day 14.
The metabolites contributing to this change in metabolic profile after altitude exposure followed two separate trajectories.
Although several haematological and non-haematological changes are well defined after hypoxic exposure (Gore et al., 2007; Reynafarje, Ramos, Faura, & Villavicencio, 1964) , to our knowledge the present study is the first to demonstrate a clear perturbation in an athlete's metabolite profile during 14 days or ∼200 h of moderate altitude exposure. Univariate statistical analysis revealed that 173
[P value of 0.03 (pFDR = 0.1)] metabolites were altered at day 3, F I G U R E 3 Loadings plot illustrating the metabolites significantly contributing to canonical variate (CV)1 (left) and CV2 (right). Data are presented as the mean loading value ± 95% confidence interval. Red-coloured metabolites are significant (P < 0.05) and contribute to the separation of each respective CV; blue-coloured metabolites do not contribute significantly to the separation day 14 or both. Altered metabolites were observed from distinct metabolite classes: amino acids, tryptophan, glycolytic, haem and nucleotide metabolic pathways. Changes in plasma amino acids were observed to decrease and might reflect metabolic remodelling in order to meet energy requirements. Decreased concentrations of several plasma amino acids, such as proline and tyrosine, during altitude exposure might reflect utilization of glucogenic substrates (Holden et al., 1995; Liao et al., 2016) . Horscroft and Murray (2014) recently suggested that promotion of amino acids as energy substrates might be favoured during high-altitude exposure. Interestingly, no evidence of increased lactate concentration was measured during moderate altitude exposure (fold change −1.38 at day 3 and −1.07 at day 14), indicating that anaerobic metabolism was unaffected at the blood sampling time points. Alternatively, increased oxidation might have occurred to prevent blunting of the erythropoietin response during early altitude exposure (Eckardt, Kurtz, & Bauer, 1990 ; Table 1 ). Additionally, when compared with baseline, we observed no differences in citrate or succinate, indicating normal tricarboxylic acid cycle activity, which is not in agreement with previously published data. For example, Liao et al. (2016) reported increased concentrations of blood lactate, succinate and citrate in 60 healthy male volunteers exposed to an altitude of 5300 m. It is likely that differences between our findings and those of Liao et al. (2016) altitudes (Lou et al., 2014) . The use of moderate altitude exposure in F I G U R E 4 Spring-embedded correlation plot illustrating metabolites (circles) and the associated correlations (lines/springs). The size of the circle is proportional to the significance of the metabolite (i.e. the larger the circle, the more significant the metabolite), and the spring relates to the amount of correlation (i.e. the shorter the spring, the more correlated the response of the metabolite to its neighbour). The direction of change is indicated by colour; red is an increase in concentration and blue a decrease in concentration relative to baseline. Node colour directly maps to the linear correlation coefficient between metabolite concentration and time (red, positive correlation; blue, negative correlation) the present study would probably have promoted different physiological responses when compared with studies completed at higher altitudes, albeit that athletes favour the use of moderate altitude so that they can continue to train effectively (Chapman, Stickford, & Levine, 2010) .
Canonical variate analysis revealed that the plasma metabolome was significantly altered after exposure to a moderate altitude of 3000 m (Figure 3 ). This finding was expected, because altitude exposure places considerable stress on the body to maintain oxygendriven energetic pathways and redox homeostasis. Importantly, changes in the plasma metabolites were observed at day 3, with a return to baseline levels by 14 days. The trajectory of the CVA aligns with the acclimatization response that typically occurs during the first 14 days of altitude exposure (Ely, Lovering, Horowitz, & Minson, 2014) . During this period, a process of biochemical and metabolic changes essential for adaptation to lower oxygen environments occurs (Ely et al., 2014) . Although many of the metabolites contributing to alteration in the athlete's metabolome remain unidentified, our findings highlight two distinct adaptation patterns occurring in athletes exposed to moderate altitude. For example, although CV1
demonstrates that metabolites initially decreased during the early phase of altitude adaptation, these metabolites appeared to return to baseline levels by day 14. In comparison, although the second trajectory (CV2) initially appeared to either increase or decrease, it did not return to baseline. To this end, further investigation of these metabolites during moderate altitude exposure might help us to describe more accurately the complex physiological and metabolic adaptations that occur in athletes during prolonged, moderate altitude exposure, which might in turn provide further insights into the physiological basis of the intra-and inter-individual differences reported in athletes during altitude exposure (McLean et al., 2014) .
The use of a spring-embedded correlation plot (Figure 4 ) identified metabolites that congregate around similar clusters and probably share related biological functions and/or metabolic pathways.
Accordingly, it is possible to infer that unidentified metabolites that also congregate around clusters of identified metabolites potentially have a similar biological function. We observed tightly clustered metabolites for the identified and significant non-identified metabolites, suggesting that these clusters were of similar biochemical relevance. For example, the close clustering of several identified and unidentified amino acids indicates that these metabolites are involved in a similar biological pathway. However, other metabolites originating from the same pathway, although detected, were either unable to be identified or were not significant, possibly owing to the small sample size (n = 10) in the present study. To this end, studies tracking larger samples of endurance athletes during sojourns to moderate altitude might provide a more complete description of the complex interaction between hypoxia and the athlete's metabolome.
Although preliminary, the present study demonstrates the potential for identifying an athlete's unique metabolic signature associated with the typical haematological and biochemical perturbations resulting from moderate altitude exposure. It is, however, important to note some limitations that might have impacted the findings of this study.
The influence of prolonged hypoxia on the athlete's metabolome remains incomplete, and further research is necessary to determine how different hypoxic training modalities influence the athlete's metabolomics profile. For example, future studies could include more sampling time points to yield a more complete understanding of the adaptation trajectory of metabolites. To this end, developing less invasive biofluid sampling mediums/matrices, such as urine and blood spots, could allow metabolic changes to be quantified more easily at moderate altitude. Furthermore, monitoring an athlete's metabolomic response in the weeks after altitude exposure might permit a better understanding of the physiological factors underlying improved endurance performance upon return to sea level. The lack of a control group and diet control in the experimental design of the present study means that we cannot be entirely sure of the biological origin of significant features observed in this study. As such, some of our metabolite findings might not be unique to altitude exposure and might possibly have been influenced by other external factors, such as the individuals' training load. Further research examining the human metabolome during other models of hypoxia, normoxia and hyperoxia and in both exercising and sedentary populations will aid in establishing whether changes in the metabolic profile are attributable to altitude exposure, training or the combination of both. Nonetheless, we observed a significant response in erythropoietin and haemoglobin mass (Govus et al., 2017) , which were consistent with the published live-high, train-low literature and indicate that an adaptation to altitude occurred (Gore et al., 2013) .
Conclusion
In conclusion, a metabolomic analysis was able to identify that 204 significantly perturbed metabolites contributed to differences in the plasma metabolome during moderate, simulated altitude exposure.
It is apparent from the present study that many metabolites remain perturbed beyond 14 days of exposure, and further investigation using more targeted methods might provide new insights into the physiological responses to altitude exposure. Finally, the outcomes of this study demonstrate the potential for metabolomics to provide more detailed information about the physiological adaptations associated with moderate altitude training.
